Palmitoyl tetrapeptide-7
Drug ingredientCAS 221227-05-0
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
3 FDA-registered drug labelers
BUDDATE Co Ltd
Guangzhou Meijiao Medical Biotechnology Co., Ltd.
Guangzhou Senmai Biotechnology Co.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •Stretch Marks cream
- •Buddate Reges Intensive Treatment
- •Instant Anti Aging Wrinkle Eye Treatment Syringe
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS221227-05-0
PubChem CID10078408
DTXSIDDTXSID10176644
FormulaC34H62N8O7
Mol. Weight694.9 g/mol
SMILESCCCCCCCCCCCCCCCC(=O)NCC(=O)NC(CCC(=O)N)C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)O
Data Sources
- PubChem · compound 10078408Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
Palmitoyl tetrapeptide-7 (CAS 221227-05-0) https://chemicalindependence.com/chemical/221227-05-0/ PubChem: 10078408. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/10078408 FDA National Drug Code directory: CAS 221227-05-0. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/